Annals of internal medicine
-
Randomized Controlled Trial Multicenter Study
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.
Biannual rituximab infusions over 18 months effectively maintain remission after a "standard" remission induction regimen for patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). ⋯ French Ministry of Health and Hoffmann-La Roche.
-
Mechanical ventilation is used to treat respiratory failure in coronavirus disease 2019 (COVID-19). ⋯ World Health Organization. (PROSPERO: CRD42020178187).
-
Comment Letter
Standard and Precordial Leads Obtained With an Apple Watch.
-
The role of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease 2019 (COVID-19) susceptibility, severity, and treatment is unclear. ⋯ None. (PROSPERO: registration number pending).